EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A clinical road map for single-cell omics

Michael A Skinnider, Gregoire Courtine, Jocelyne Bloch, Jordan W Squair

Cell · 2025-07 · 188 (14) · 3633-3647

DOI: 10.1016/j.cell.2025.06.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell, 2025-07. Verfasst von Michael A Skinnider und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA; Ludwig Institute for Cancer Research, Princeton University…. Hauptthemen laut MEDLINE: Single-Cell Analysis, Genomics. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ludwig Institute for Cancer Research, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a matter of years, single-cell omics has matured from a pioneering technique employed by just a handful of specialized laboratories to become a ubiquitous feature of biological research and a key driver of scientific discovery. The widespread adoption and development of single-cell omic assays has sparked mounting enthusiasm that these technologies are poised to also enhance the precision of diagnosis, the monitoring of disease progression, and the personalization of therapeutic strategies. Despite initial forays into clinical settings, however, single-cell technologies are not yet routinely used to inform medical or surgical decision-making. Here, we identify and categorize key experimental, computational, and conceptual barriers that currently hinder the clinical deployment of single-cell omics. We focus on the potential for single-cell transcriptomics to guide clinical decision-making through the development of combinatorial biomarkers that simultaneously quantify multiple cell-type-specific pathophysiological processes. We articulate a framework to identify patient subpopulations that stand to benefit from such biomarkers, and we outline the experimental and computational requirements to derive reproducible and actionable clinical readouts from single-cell omics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Cell AnalysisGenomicsHumansTranscriptomeBiomarkersComputational BiologyProteomicsGene Expression ProfilingPrecision Medicine

Stichwörter der Autor:innen

machine learningpatient cohortspersonalized medicinesingle-cellspatial transcriptomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA. Electronic address: skinnider@princeton.edu.
  • NeuroRestore, CHUV/UNIL/EPFL, Lausanne, Switzerland; NeuroX Institute, School of Life Sciences, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland; Department of Clinical Neuroscience, Lausanne Universi…

Förderung

  • Ludwig Institute for Cancer Research
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Skinnider, M. A., Courtine, G., Bloch, J., & Squair, J. W. (2025). A clinical road map for single-cell omics. Cell, 188(14), 3633-3647. https://doi.org/10.1016/j.cell.2025.06.009

Vancouver

Skinnider MA, Courtine G, Bloch J, Squair JW. A clinical road map for single-cell omics. Cell. 2025;188(14):3633-3647. doi:10.1016/j.cell.2025.06.009

BibTeX
@article{Skinnider2025,
  author = {Skinnider, Michael A and Courtine, Gregoire and Bloch, Jocelyne and Squair, Jordan W},
  title = {A clinical road map for single-cell omics},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {14},
  pages = {3633--3647},
  doi = {10.1016/j.cell.2025.06.009}
}
Kostenlos starten →